Zombie Yellow™ Fixable Viability Kit

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixable Dye, Fixable Viability Dye
Ave. Rating
Submit a Review
Product Citations
publications
Zombie_Yellow_Viability_Dye_050713
One day old C57BL/6 mouse splenocytes were stained with Zombie Yellow™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie Yellow™ staining, are indicated in black.
  • Zombie_Yellow_Viability_Dye_050713
    One day old C57BL/6 mouse splenocytes were stained with Zombie Yellow™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie Yellow™ staining, are indicated in black.
See Zombie Yellow™ spectral data
Cat # Size Price Quantity Check Availability Save
423103 100 tests 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423104 500 tests 268€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie Yellow™ is an amine-reactive fluorescent dye that is non-permeant to live cells but permeant to the cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie Yellow™ is a polar, water soluble dye providing bright yellow fluorescence, making it suitable for multi-color detection.

Product Details
Technical data sheet

Product Details

Preparation
Zombie Yellow™ Fixable Viability Kit is composed of lyophilized Zombie Yellow™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Yellow™ dye until fully dissolved. 100 tests = 1 vial of Zombie Yellow™ + DMSO, 500 tests = 5 vials of Zombie Yellow™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie Yellow™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application

FC - Quality tested

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

Excitation Laser
Violet Laser (405 nm)
Application Notes

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrofuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Yellow™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie Yellow™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µl Zombie Yellow™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µl for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.

    Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.

  5. Incubate the cells at room temperature, in the dark, for 15-30 minutes.
  6. Wash one time with 2 ml BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

 

No-wash Sequential Staining Protocol:

 

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Yellow™ dye and mix until fully  dissolved
  3. Determine the total µl volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µl. Subtract that antibody volume from the 100 µl total staining volume intended for the assay. In the remaining volume, dilute Zombie Yellow™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µl of antibody cocktail for a 100 µl total staining volume, use 80 µl of Zombie Yellow™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie Yellow™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.

    Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.

  4. Incubate for 10-15 minutes at RT, protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.


Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie Yellow™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie Yellow™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie Yellow™.

Zombie Yellow™ dye is excited by the violet laser and has a fluorescence emission maximum of 572 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie Yellow™ dye has similar emission to Brilliant Violet 570™.

Application References

(PubMed link indicates BioLegend citation)
  1. Talabot-Ayer D, et al. 2015. J Immunol. 194:750. PubMed
  2. Keppel MP, et al. 2015. J Immunol. 194:1954. PubMed
  3. Shade KT, et al. 2015. J Exp Med. 212:457. PubMed
  4. Souza-Fonesca-Guimaraes F, et al. 2015. PNAS. 112:2376. PubMed
  5. Weiser JN, et al. 2015. J Infect Dis. PubMed
Product Citations
  1. Makaryan V, et al. 2022. J Cell Immunol. 4:19. PubMed
  2. Souza-Fonseca-Guimaraes F, et al. 2016. Cell Death Dis. 7:e2302. PubMed
  3. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  4. Ye Y, et al. 2022. Nat Commun. 13:6458. PubMed
  5. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  6. Zhou T, et al. 2020. Nature. 583:609. PubMed
  7. Schimek V, et al. 2022. Cell Death Dis. 13:113. PubMed
  8. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  9. Park SY, et al. 2022. NPJ Vaccines. 7:123. PubMed
  10. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  11. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  12. Weiser J, et al. 2015. J Infect Dis. 212: 1677 - 1682. PubMed
  13. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  14. Murayama G,et al. 2017. Arthritis Res Ther.. 10.1186/s13075-017-1441-7. PubMed
  15. Souza-Fonseca-Guimaraes F, et al. 2015. Proc Natl Acad Sci U S A. 112:2376. PubMed
  16. Booty MG, et al. 2022. J Immunol. 208:929. PubMed
  17. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  18. Kobayashi Y, et al. 2020. Int J Oncol. 999:56. PubMed
  19. Peterson L, et al. 2016. J Immunol. 197: 4110 - 4117. PubMed
  20. Philip N, et al. 2016. PLoS Pathog. 12:e1005910. PubMed
  21. Renshaw H, et al. 2016. Infect Immun . 84: 1556 - 1564. PubMed
  22. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  23. El–Achkar GA, et al. 2019. PLoS One. 14:e0216405. PubMed
  24. Alturki NA, et al. 2018. Cell Death Dis. 9:592. PubMed
  25. Mathivet T, et al. 2017. EMBO Mol Med.. 10.15252/emmm.201607445. PubMed
  26. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  27. Fisher J, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.03.002. PubMed
  28. Hoppstädter J, et al. 2019. Front Immunol. 10:1634. PubMed
  29. Haines RR, et al. 2018. J Immunol. 201:2799. PubMed
  30. Valbuena Perez JV, et al. 2020. Aging Cell. 19:e13156. PubMed
  31. Perales-Puchalt A, et al. 2017. Clin Cancer Res. 23(2):441-453. PubMed
  32. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  33. Hole CR, et al. 2019. Nat Commun. 10:2955. PubMed
  34. Lima LG, et al. 2021. Nat Commun. 12:3543. PubMed
  35. Wang JC, et al. 2022. Elife. 11:. PubMed
  36. Talabot-Ayer D, et al. 2015. J Immunol. 194:750. PubMed
  37. Keppel M, et al. 2015. J Immunol. 194:1954. PubMed
  38. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  39. Chung NH, et al. 2022. Vaccine. 40:574. PubMed
  40. Rajamanickam V, et al. 2021. Cancer Immunol Res. 9:602. PubMed
  41. Zhang S, et al. 2021. Cancer Discov. 0.709722222. PubMed
  42. Putz EJ, et al. 2019. J Dairy Sci. 102:9268. PubMed
  43. Grubišic V, et al. 2022. Mucosal Immunol. 15:964. PubMed
  44. Islam MR, et al. 2022. Nanotheranostics. 6:451. PubMed
  45. Zanvit P, et al. 2015. Nat Commun. 6: 8424. PubMed
  46. Lombardi M, et al. 2016. J Leukoc Biol. 99: 711 - 721. PubMed
  47. Palomo J, et al. 2016. J Immunol. 197: 2239 - 2249. PubMed
  48. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  49. Lim J, et al. 2022. J Exp Med. 219:. PubMed
  50. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  51. Keller A, et al. 2017. Nat Immunol. 18:402-411. PubMed
  52. Tanaka Y, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.46. PubMed
  53. Huang N, et al. 2020. Genome Biol. 1.03125. PubMed
  54. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  55. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  56. Fukumoto T, et al. 2019. Cancer Res. 79:5482. PubMed
  57. Davidson TB, et al. 2019. Clin Cancer Res. 25:1913. PubMed
  58. Mittal D, et al. 2016. Cancer Res . 76: 264 - 274. PubMed
  59. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  60. Behrens GMN, et al. 2022. Nat Commun. 13:4872. PubMed
  61. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  62. Shorter S, et al. 2016. PLoS One. 11: 0149582. PubMed
  63. Herati RS, et al. 2022. Nat Immunol. 23:1183. PubMed
  64. Binette P, et al. 2022. Front Immunol. 13:894536. PubMed
  65. Egedal JH, et al. 2021. Mucosal Immunol. 14:1203. PubMed
  66. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  67. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  68. Singh KS, et al. 2021. Nature. 589:597. PubMed
  69. Tzeng TT, et al. 2022. NPJ Vaccines. 7:60. PubMed
  70. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  71. Trial J, et al. 2020. Geroscience. . PubMed
  72. Tao Z, et al. 2022. Cells. 11:. PubMed
  73. DeFalco T, et al. 2016. Cell Rep. 12: 1107-1119. PubMed
  74. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  75. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  76. Waldman MM, et al. 2022. Front Immunol. 13:856977. PubMed
  77. Teshima T, et al. 2022. Oncol Lett. 24:265. PubMed
  78. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  79. Haines RR, et al. 2019. J Immunol. 203:1867. PubMed
  80. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  81. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  82. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can I use Zombie dyes for microscopy?

Zombie dyes tested in-house for microscopy applications will display data on the product technical datasheet. It should be noted that Zombie dyes may not work for dead cell discrimination in every microscopy application. Important considerations that may impact analysis are determining the signal level that constitutes a dead cell and identifying the proper plane to observe the dead cells.

Why can't I fix my cells prior to using Zombie dyes?

The fixation process can contort and alter the membrane of cells, effectively rendering them dead. Since the ability of the Zombie dyes to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Can I use Zombie dyes to detect apoptotic cells?

Yes, Zombie dyes can be used with apoptosis markers, such as Annexin V or Apotracker™ (shown below), to discriminate live, apoptotic, and dead cells.

One day-old C57BL/6 mouse thymocytes were stained with Apotracker™ Tetra Alexa Fluor® 647 and Zombie™ YG581. Zombie-dim/Apotracker™-positive cells are apoptotic, while double-positive cells are dead. Live cells are negative for both markers.

How should I store Zombie dyes?

Store the Zombie dye kit at -20°C upon receipt. Do not open vials until needed. Once DMSO is added, use immediately or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.

Go To Top Version: 5    Revision Date: 05.20.2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account